Opko Health

Yahoo Finance • last month

OPKO Health (OPK) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Date Feb. 26, 2026 Call participants Chairman and Chief Executive Officer — Phillip FrostVice Chairman and President — Elias ZerhouniChief Financial Officer — Adam E. LogalIndependent Director and Chief I... Full story

Yahoo Finance • 2 months ago

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development

Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $3 to invest in. On February 4, Opko Health Inc. (NASDAQ:OPK) announced it expanded its partnership with Entera Bio Ltd., a company developing oral peptide and protein replaceme... Full story

Yahoo Finance • 5 months ago

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Pa... Full story

Yahoo Finance • 5 months ago

NextPlat Reports Third Quarter 2025 Results

Company Reports $13.8M in Q3 Revenue as Refocusing and Cost Cutting Initiatives Drive Improved Late Quarter Performance with Accelerated Sequential Improvements Expected in Q4 and into 2026 HALLANDALE BEACH, Fla., Nov. 13, 2025 /PRNewswir... Full story

Yahoo Finance • 5 months ago

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights from the third quarter of 2025 and rece... Full story

Yahoo Finance • 5 months ago

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers

OPKO Health, Inc. First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28, 20... Full story

Yahoo Finance • 6 months ago

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, O... Full story

Yahoo Finance • 8 months ago

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics

We recently published 12 Best Healthcare Stocks to Buy Under $30. OPKO Health, Inc. (NASDAQ:OPK) is one of the best healthcare stocks. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations in diagnostics, phar... Full story

Yahoo Finance • 8 months ago

Opko Health earnings missed by $0.08, revenue fell short of estimates

Investing.com - Opko Health (NASDAQ: OPK) reported second quarter EPS of $-0.190, $0.08 worse than the analyst estimate of $-0.113. Revenue for the quarter came in at $156.8M versus the consensus estimate of $165.7M. Opko Health’s stock... Full story

Yahoo Finance • 8 months ago

OPKO Health Inc (NASDAQ:OPK) Q2 2025 Earnings Miss Estimates, Stock Plunges 7.8%

OPKO Health Inc (NASDAQ:OPK [https://www.chartmill.com/stock/quote/OPK]) reported its second-quarter 2025 financial results, missing analyst expectations on both revenue and earnings per share (EPS). The company’s stock fell sharply in aft... Full story

Yahoo Finance • 8 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

OPKO Health, Inc. Conference call begins at 4:30 p.m. Eastern time today MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 3... Full story

Yahoo Finance • 9 months ago

OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX)

OPKO Health, Inc. (NASDAQ:OPK) is one of the Best American Penny Stocks to Buy According to Analysts. On July 8, OPKO Health, Inc. (NASDAQ:OPK) in collaboration with Entera Bio Ltd. (NASDAQ: ENTX) announced the selection of their Oral GLP-... Full story

Yahoo Finance • 9 months ago

H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3

Opko Health Inc. (NASDAQ:OPK) is one of the 13 Stocks Under $5 With High Upside Potential. On May 1, analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on Opko Health Inc. (NASDAQ:OPK), retaining the price target of $3.00. Despite... Full story

Yahoo Finance • 10 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fir... Full story

Yahoo Finance • 10 months ago

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline includes first-in class drugs with two as... Full story

Yahoo Finance • 11 months ago

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...

Diagnostics Segment Revenue: $102.8 million in Q1 2025, including $25.1 million from assets being sold to LabCorp, compared to $126.9 million in Q1 2024. Diagnostics Segment Costs and Expenses: $126.8 million in Q1 2025, including $32.4 mi... Full story

Yahoo Finance • 12 months ago

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

OPKO Health, Inc. MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Wednesd... Full story

Yahoo Finance • last year

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKOHealth,Inc.(NASDAQ:OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregat... Full story

Yahoo Finance • last year

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and... Full story

Yahoo Finance • last year

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth quarter of 2024 and recent weeks... Full story